| 1 |
21178279 | A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control. | 2010 |
1 |
| 2 |
19635153 | Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer. | 2009 |
1 |
| 3 |
1563830 | Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts. | 1992 Apr 22 |
1 |
| 4 |
1735615 | Influence of dose and schedule on the therapeutic efficacy of 131I-labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft model. | 1992 Feb 1 |
1 |